Helen Caldwell Division of Pathology University of Edinburgh Biography Publications Institution JoVE Articles Helen Caldwell has not added a biography. If you are Helen Caldwell and would like to personalize this page please email our Author Liaison for assistance. Publications Cibler Un Blocage Rac GTPases La Propagation Du Cancer Du Sein Humain Intact Oncotarget. Jun, 2012 | Pubmed ID: 22689141 Un Modèle in Vitro Qui Récapitule L'transition épithélio-mésenchymateuse (EMT) Dans Le Cancer Du Sein Humain PloS One. 2011 | Pubmed ID: 21347235 Rapide Catalysée Par Le Ruthénium Allylation De Thiols En Utilisant Des Alcools Allyliques Comme Substrats Chemistry (Weinheim an Der Bergstrasse, Germany). Jun, 2009 | Pubmed ID: 19466722 Analyse De Microarray De L'expression Génique Des Hépatocytes De Souris De Ploïdie Mammalian Genome : Official Journal of the International Mammalian Genome Society. Sep, 2007 | Pubmed ID: 17726633 TNF-alpha Induite Dans L'ADN Des Dommages Hépatocytes Primaires Murins International Journal of Molecular Medicine. Dec, 2003 | Pubmed ID: 14612962 L'utilisation des puces à protéines de phase inversée (RPPA) Variation à explorer l'expression des protéines dans les cancers à cellules rénales individuels Fiach C. O'Mahony1, Jyoti Nanda1, Alexander Laird1, Peter Mullen2, Helen Caldwell3, Ian M. Overton4, Lel Eory4, Marie O'Donnell1,5, Dana Faratian6, Thomas Powles7, David J. Harrison1,2, Grant D. Stewart1 1Edinburgh Urological Cancer Group, University of Edinburgh, 2School of Medicine, University of St Andrews, 3Division of Pathology, University of Edinburgh, 4MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, 5Department of Pathology, Western General Hospital, 6Breakthrough Breast Cancer Research Unit, University of Edinburgh, 7St Bartholomew's Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London JoVE 50221 Medicine
L'utilisation des puces à protéines de phase inversée (RPPA) Variation à explorer l'expression des protéines dans les cancers à cellules rénales individuels Fiach C. O'Mahony1, Jyoti Nanda1, Alexander Laird1, Peter Mullen2, Helen Caldwell3, Ian M. Overton4, Lel Eory4, Marie O'Donnell1,5, Dana Faratian6, Thomas Powles7, David J. Harrison1,2, Grant D. Stewart1 1Edinburgh Urological Cancer Group, University of Edinburgh, 2School of Medicine, University of St Andrews, 3Division of Pathology, University of Edinburgh, 4MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, 5Department of Pathology, Western General Hospital, 6Breakthrough Breast Cancer Research Unit, University of Edinburgh, 7St Bartholomew's Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London JoVE 50221 Medicine